the hypolipidaemic effect of a new drug , gemfibrozil ( ci-719 ) , was studied for 20 weeks in 20 patients with primary type iib , iii , iv or v hyperlipoproteinaemia .
C0017245
gemfibrozil
C0020476
hyperlipoproteinaemia